The DOI matches its Crossref record; 481 of the 481 references it cites were found in a registry or an index.
Genomic instability in human cancer: Molecular insights and opportunities for therapeutic attack and prevention through diet and nutrition
Open accessAbstract
Genomic instability can initiate cancer, augment progression, and influence the overall prognosis of the affected patient. Genomic instability arises from many different pathways, such as telomere damage, centrosome amplification, epigenetic modifications, and DNA damage from endogenous and exogenous sources, and can be perpetuating, or limiting, through the induction of mutations or aneuploidy, both enabling and catastrophic. Many cancer treatments induce DNA damage to impair cell division on a global scale but it is accepted that personalized treatments, those that are tailored to the particular patient and type of cancer, must also be developed. In this review, we detail the mechanisms from which genomic instability arises and can lead to cancer, as well as treatments and measures that prevent genomic instability or take advantage of the cellular defects caused by genomic instability. In particular, we identify and discuss five priority targets against genomic instability: (1) prevention of DNA damage; (2) enhancement of DNA repair; (3) targeting deficient DNA repair; (4) impairing centrosome clustering; and, (5) inhibition of telomerase activity. Moreover, we highlight vitamin D and B, selenium, carotenoids, PARP inhibitors, resveratrol, and isothiocyanates as priority approaches against genomic instability. The prioritized target sites and approaches were cross validated to identify potential synergistic effects on a number of important areas of cancer biology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Items 401–481 of 481
Lycopene activity against chemically induced DNA damage in Chinese hamster ovary cells
Scolastici, C., de Lima, R. O. A., Barbisan, L. F., Ferreira, A. L. A., Ribeiro, D. A., & Salvadori, D. M. F. (2007) · Toxicology in Vitro · doi:10.1016/j.tiv.2007.01.020 · Cited by 49
Lin, S.-Y., Lee, W.-R., Su, Y.-F., Hsu, S.-P., Lin, H.-C., Ho, P.-Y., Hou, T.-C., Chou, Y.-P., Kuo, C.-T., & Lee, W. (2012) · Angiogenesis · doi:10.1007/s10456-012-9289-6 · Cited by 49
Review. Pro- and anti-angiogenesis effects of resveratrol.
Chen, Y., & Tseng, S. (2007) · PubMed · Cited by 49
NuMA is required for proper spindle assembly and chromosome alignment in prometaphase
Haren, L., Gnadt, N., Wright, M., & Merdes, A. (2009) · BMC Research Notes · doi:10.1186/1756-0500-2-64 · Cited by 48
Resveratrol Prevents Dendritic Cell Maturation in Response to Advanced Glycation End Products
Buttari, B., Profumo, E., Facchiano, F., Ozturk, E. I., Segoni, L., Saso, L., & Riganò, R. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/574029 · Cited by 48
The E2 Ubiquitin Conjugase Rad6 Is Required for the ArgR/Mcm1 Repression of ARG1 Transcription
Turner, S. D., Ricci, A. R., Petropoulos, H., Genereaux, J. L., Skerjanc, I. S., & Brandl, C. J. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.12.4011-4019.2002 · Cited by 48
Genistein and β-carotene enhance the growth-inhibitory effect of trichostatin A in A549 cells
Shiau, R.-J., Chen, K.-Y., Wen, Y.-D., Chuang, C., & Yeh, S.-L. (2009) · European Journal of Nutrition · doi:10.1007/s00394-009-0044-8 · Cited by 47
Haddad, N. F., Teodoro, A. J., de Oliveira, F. L., Soares, N. D. C. P., de Mattos, R. M., Hecht, F., Dezonne, R. S., Vairo, L., Goldenberg, R. C. D. S., Gomes, F. C. A., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062773 · Cited by 47
Vitamin D Receptor is a Novel Drug Target for Ovarian Cancer Treatment
Zhang, X., Nicosia, S. V., & Bai, W. (2006) · Current Cancer Drug Targets · doi:10.2174/156800906776842939 · Cited by 47
Krishnan, A. V., Swami, S., & Feldman, D. I. (2012) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2012.08.005 · Cited by 46
Telomere DNA Content Predicts Breast Cancer–Free Survival Interval
Heaphy, C. M., Baumgartner, K. B., Bisoffi, M., Baumgartner, R., & Griffith, J. K. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0432 · Cited by 46
Park, E. Y., Wilder, E. T., & Lane, M. A. (2007) · Nutrition and Cancer · doi:10.1080/01635580701268238 · Cited by 45
P21-PARP-1 Pathway Is Involved in Cigarette Smoke-Induced Lung DNA Damage and Cellular Senescence
Yao, H., Sundar, I. K., Gorbunova, V. A., & Rahman, I. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080007 · Cited by 45
Liang, Y., Gao, H., Lin, S., Goss, J. A., Brunicardi, F. C., & Li, K. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012860 · Cited by 44
Dietary Carotenoids and Genetic Instability Modify Bladder Cancer Risk
Schabath, M. B., Grossman, H. B., Delclos, G. L., Hernandez, L. M., Day, R. S., Davis, B. R., Lerner, S. P., Spitz, M. R., & Wu, X. (2004) · Journal of Nutrition · doi:10.1093/jn/134.12.3362 · Cited by 44
Huang, P., Lin, C.-P., Wang, C., Chiang, C.-H., Tsai, H., Chen, J.-S., Lin, F.-Y., Leu, H., Wu, T.-C., Chen, J., et al. (2012) · Angiogenesis · doi:10.1007/s10456-012-9267-z · Cited by 43
Resveratrol suppresses tumor progression via the regulation of indoleamine 2,3-dioxygenase
Noh, K. T., Chae, S. H., Chun, S. H., Jung, I. D., Kang, H. K., & Park, Y. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.12.093 · Cited by 43
Dai, C., Sun, F., Zhu, C., & Hu, X. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063054 · Cited by 43
Sharp, L., Carsin, A., Cantwell Marie, M., Anderson, L. A., & Murray Liam, J. (2013) · Journal of Nutrition · doi:10.3945/jn.113.174664 · Cited by 42
Jang, S. H., Lim, J. W., & Kim, H. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04711.x · Cited by 42
Briviba, K., Bub, A., Möseneder, J., Schwerdtle, T., Hartwig, A., Kulling, S. E., & Watzl, B. (2008) · Nutrition and Cancer · doi:10.1080/01635580701621346 · Cited by 41
DNA Repair and Cancer Therapy: Targeting APE1/Ref-1 Using Dietary Agents
Raffoul, J. J., Heydari, A. R., & Hillman, G. G. (2012) · Journal of Oncology · doi:10.1155/2012/370481 · Cited by 41
Synthetic Genetic Targeting of Genome Instability in Cancer
Sajesh, B. V., Guppy, B. J., & McManus, K. J. (2013) · Cancers · doi:10.3390/cancers5030739 · Cited by 40
Falchetti, M. L., Mongiardi, M. P., Fiorenzo, P., Petrucci, G., Pierconti, F., D’Agnano, I., D’Alessandris, Q. G., Alessandri, G., Gelati, M., Ricci‐Vitiani, L., et al. (2007) · International Journal of Cancer · doi:10.1002/ijc.23193 · Cited by 39
Novel germline PALB2 truncating mutations in African American breast cancer patients
Zheng, Y., Zhang, J., Niu, Q., Huo, D., & Olopade, O. I. (2011) · Cancer · doi:10.1002/cncr.26388 · Cited by 38
Morin, B., Narbonne, J., Ribera, D., Badouard, C., & Ravanat, J. (2007) · Food and Chemical Toxicology · doi:10.1016/j.fct.2007.10.011 · Cited by 37
Following Mitochondrial Footprints through a Long Mucosal Path to Lung Cancer
Dasgupta, S., Yung, R., Westra, W. H., Rini, D. A., Brandes, J. C., & Sidransky, D. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006533 · Cited by 36
Self-citationEpigenetic inactivation of DNA repair in breast cancer
Nowsheen, S., Aziz, K., Tran, P. T., Gorgoulis, V. G., Yang, E. S.-H., & Georgakilas, A. G. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.05.015 · Cited by 36
Self-citationLiu, L., Berletch, J. B., Green, J. G., Pate, M. S., Andrews, L. G., & Tollefsbol, T. O. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.1003.3.8 · Cited by 36
Çalışkan-Can, E., Fırat, H., Ardıç, S., Şimşek, B., Torun, M., & Yardım-Akaydin, S. (2008) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2008.010 · Cited by 35
Update on PARP1 inhibitors in ovarian cancer
Sessa, C. (2011) · Annals of Oncology · doi:10.1093/annonc/mdr528 · Cited by 35
The accumulation of DNA repair defects is the molecular origin of carcinogenesis
Cha, H., & Yim, H. (2013) · Tumor Biology · doi:10.1007/s13277-013-1038-y · Cited by 34
Shen, S., Mao, C.-Q., Yang, X., Du, X., Liu, Y., Zhu, Y., & Wang, J. (2014) · Molecular Pharmaceutics · doi:10.1021/mp400714z · Cited by 34
Self-citationDeeb, D., Gao, X., Liu, Y., Kim, S.-H., Pindolia, K. R., Arbab, A. S., & Gautam, S. C. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.05.024 · Cited by 33
Lee, S. C., Chan, J. Y., & Pervaiz, S. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.06.020 · Cited by 33
Effects of ascorbic acid and β-carotene on HepG2 human hepatocellular carcinoma cell line
Yurtçu, E., İşeri, Ö. D., & Şahin, F. İ. (2010) · Molecular Biology Reports · doi:10.1007/s11033-010-0549-5 · Cited by 32
Telomere reduction in endometrial adenocarcinoma
Smith, J. K., & Yeh, G. L. (1992) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(92)91791-8 · Cited by 32
Stan, S. D., Singh, S. V., Whitcomb, D. C., & Brand, R. E. (2013) · Nutrition and Cancer · doi:10.1080/01635581.2013.795979 · Cited by 32
Kandaş, N. Ö., Horton, L., Lasano, S. G., & Bosland, M. C. (2010) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-09-0152 · Cited by 32
Nishikawa, K., Rosenblum, M. G., Newman, R. A., Pandita, T. K., Hittelman, W. N., & Donato, N. J. (1992) · PubMed · Cited by 31
Molecular Hepatic Carcinogenesis: Impact of Inflammation
Szabó, G., & Lippai, D. (2012) · Digestive Diseases · doi:10.1159/000336913 · Cited by 31
ASTLEY, S. B., Elliott, R. M., Archer, D. B., & Southon, S. (2002) · Nutrition and Cancer · doi:10.1207/s15327914nc432_11 · Cited by 31
Hager, G., Kornfehl, J., Knerer, B., et al. (2004) · Acta Oto-Laryngologica · doi:10.1080/00016480310015353 · Cited by 31
Venturini, L., Daidone, M. G., Motta, R., Cimino-Reale, G., Hoare, S. F., Gronchi, A., Folini, M., Keith, W. N., & Zaffaroni, N. (2012) · Neuro-Oncology · doi:10.1093/neuonc/nos083 · Cited by 31
Self-citationLagadu, S., Lechevrel, M., Sichel, F., Breton, J., Pottier, D., Couderc, R., Moussa, F., & Prevost, V. (2010) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-29-157 · Cited by 31
Thomson, S. J., Brown, K., Pullar, J. M., & Hampton, M. B. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3809 · Cited by 31
Germline mutations in PALB2 in African-American breast cancer cases
Ding, Y. C., Steele, L., Chu, L.-H., et al. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-1271-7 · Cited by 31
Kelvin, E. A., Edwards, S., Jedrychowski, W. A., Schleicher, R. L., Camann, D., Tang, D. L., & Perera, F. P. (2009) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-09-0316 · Cited by 31
Zhou, G.-D., Richardson, M., Fazili, I. S., Wang, J., Donnelly, K. C., Wang, F., Amendt, B. A., & Moorthy, B. (2010) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2010.09.019 · Cited by 30
β-Carotene Reduces Bleomycin-Induced Genetic Damage in Human Lymphocytes
Glei, M., Liegibel, U. M., Ebert, M. N., Böhm, V., & Pool-Zobel, B. L. (2002) · Toxicology and Applied Pharmacology · doi:10.1006/taap.2001.9329 · Cited by 29
Epigenetic regulation of telomerase in retinoid-induced differentiation of human leukemia cells
Love, W. K., Berletch, J. B., Andrews, L., & Tollefsbol, T. O. (2008) · International Journal of Oncology · doi:10.3892/ijo.32.3.625 · Cited by 28
Role of AMP-Activated Protein Kinase in Ferritin H Gene Expression by Resveratrol in Human T Cells
Iwasaki, K., Ray, P. D., Huang, B., Sakamoto, K., Kobayashi, T., & Tsuji, Y. (2013) · Biochemistry · doi:10.1021/bi400399f · Cited by 28
Zhang, M., Zhou, X., & Zhou, K. (2013) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2013.1237 · Cited by 28
Yang, E. S.-H., Nowsheen, S., Rahman, M. A., Cook, R. S., & Xia, F. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-0934 · Cited by 28
Self-citationStilbenes as multidrug resistance modulators and apoptosis inducers in human adenocarcinoma cells.
Wesołowska, O., Wiśniewski, J. Ł., Bielawska‐Pohl, A., Paprocka, M., Duarte, N., Ferreira, M. U., Duś, D., & Michalak, K. (2010) · PubMed · Cited by 27
An IKKα-Nucleophosmin Axis Utilizes Inflammatory Signaling to Promote Genome Integrity
Xia, X., Liu, S., Xiao, Z., Zhu, F., Song, N., Zhou, M., Liu, B., Shen, J., Nagashima, K., Veenstra, T. D., et al. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.10.046 · Cited by 26
Keith, M. E., LaPorta, E., & Welsh, J. (2013) · Molecular Carcinogenesis · doi:10.1002/mc.21975 · Cited by 23
Therapeutic potential of PARP inhibitors for metastatic breast cancer
Irshad, S., Ashworth, A., & Tutt, A. N. J. (2011) · Expert Review of Anticancer Therapy · doi:10.1586/era.11.52 · Cited by 23
Chen, P., Peng, J., Huang, L., Li, W., WANG, W.-Z., CUI, Z.-Q.-Q., Han, H., Gong, L., XIANG, D.-P., Qiao, S., et al. (2013) · Oncology Reports · doi:10.3892/or.2013.2563 · Cited by 22
Ohshima, S. (2012) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2012/217594 · Cited by 21
Targeting critical steps of cancer metastasis and recurrence using telomerase template antagonists
Dikmen, Z. G., Özgürtaş, T., Gryaznov, S. M., & Herbert, B. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.01.018 · Cited by 21
Kontek, R., Drozda, R., Śliwiński, M., & Grzegorczyk, K. (2009) · Toxicology in Vitro · doi:10.1016/j.tiv.2009.10.013 · Cited by 20
Aroni, K., Anagnostopoulou, K. K., Tsagroni, E., & Ioannidis, E. (2008) · Acta Dermato Venereologica · doi:10.2340/00015555-0377 · Cited by 20
Mitogenic and Apoptotic Signaling by Carotenoids: Involvement of a Redox Mechanism
Palozza, P., Serini, S., Nicuolo, F. D., & Calviello, G. (2001) · IUBMB Life · doi:10.1080/15216540252774810 · Cited by 20
Huang, C., & Hu, M. (2011) · Food and Chemical Toxicology · doi:10.1016/j.fct.2011.03.023 · Cited by 17
Genetic inhibition of telomerase results in sensitization and recovery of breast tumor cells
Poynter, K. R., Sachs, P. C., Bright, A. T., Breed, M. S., Nguyen, B. N., Elmore, L. W., & Holt, S. E. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0849 · Cited by 17
Vitamin A effect on tumor angiogenesis
ARENSMAN, R. M., & Stolar, C. J. H. (1979) · Journal of Pediatric Surgery · doi:10.1016/s0022-3468(79)80271-7 · Cited by 16
Bringing H2AX into the Angiogenesis Family
Rankin, E. B., Giaccia, A. J., & Hammond, E. M. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.05.004 · Cited by 16
Bergström, T. B., Bergman, J., & Möller, L. (2011) · Mutagenesis · doi:10.1093/mutage/ger041 · Cited by 16
Li, R. W., Li, C., & Wang, T. T. Y. (2012) · Molecular Carcinogenesis · doi:10.1002/mc.21873 · Cited by 15
Tenesa, A., Farrington, S. M., & Dunlop, M. G. (2005) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dji051 · Cited by 15
Zhang, J., Kan, Y., Tian, Y., Wang, Z., & Zhang, J. (2013) · PubMed Central · Cited by 15
Kuklin, A. I., Mynatt, R. L., Klebig, M. L., Kiefer, L. L., Wilkison, W. O., Woychik, R. P., & Michaud, E. J. (2004) · Molecular Cancer · doi:10.1186/1476-4598-3-17 · Cited by 14
Błasiak, J., Kadłubek, M., Kowalik, J., Romanowicz‐Makowska, H., & Pertyński, T. (2001) · Teratogenesis Carcinogenesis and Mutagenesis · doi:10.1002/tcm.1040 · Cited by 14
Angiogenesis: escape from hypoxia
Coleman, M. L., & Ratcliffe, P. J. (2009) · Nature Medicine · doi:10.1038/nm0509-491 · Cited by 13
Walking the Telomere Plank Into Cancer
Wong, K., & DePinho, R. A. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djg028 · Cited by 13
Park, E. Y., Pinali, D., Lindley, K., & Lane, M. A. (2012) · Nutrition and Cancer · doi:10.1080/01635581.2012.687425 · Cited by 12
Kim, Y. M., Yang, S., Xu, W., Li, S., & Yang, X. (2008) · Cancer Genetics and Cytogenetics · doi:10.1016/j.cancergencyto.2008.06.010 · Cited by 11
Self-citationA possible crosstalk between DNA repair pathways and angiogenesis
Chavakis, T., Orlova, V. V., & Langer, H. F. (2009) · Cell Cycle · doi:10.4161/cc.8.21.9750 · Cited by 8
Nassani, N., Khayat, G., RAAD, I. I., Jiang, Y., Alaaeddine, N., & Hilal, G. (2013) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2013.07.018 · Cited by 4
Cited by
The Molecular Taxonomy of Primary Prostate Cancer
Abeshouse, A., Ahn, J., Akbani, R., Ally, A., Amin, S., Andry, C. D., Annala, M., Aprikian, A., Armenia, J., Arora, A., et al. (2015) · Cell · doi:10.1016/j.cell.2015.10.025 · Cited by 3,110
State-of-the-art strategies for targeting the DNA damage response in cancer
Pilié, P. G., Tang, C., Mills, G. B., & Yap, T. A. (2019) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-018-0114-z · Cited by 1,189
Stem cell divisions, somatic mutations, cancer etiology, and cancer prevention
Tomasetti, C., Li, L., & Vogelstein, B. (2017) · Science · doi:10.1126/science.aaf9011 · Cited by 1,113
Lung Cancer—Epidemiology, Pathogenesis, Treatment and Molecular Aspect (Review of Literature)
Smolarz, B., Łukasiewicz, H., Samulak, D., Piekarska, E., Kołaciński, R., & Romanowicz, H. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26052049 · Cited by 259
Genetic etiology of oral cancer
Ali, J., Sabiha, B., Jan, H. U., Haider, S. A., Khan, A. A., & Ali, S. S. (2017) · Oral Oncology · doi:10.1016/j.oraloncology.2017.05.004 · Cited by 256
Metadata
- Authors
- Ferguson, L. R., Chen, H., Collins, A. R., Connell, M., Damia, G., Dasgupta, S., Malhotra, M., Meeker, A. K., Amedei, A., Amin, A., Ashraf, S. S., Aquilano, K., Azmi, A. S., Bhakta, D., Bilsland, A., Boosani, C. S., Chen, S., Ciriolo, M. R., Fujii, H., Guha, G., Halicka, D., Helferich, W. G., Keith, W. N., Mohammed, S. I., Niccolai, E., Yang, X., Honoki, K., Parslow, V. R., Prakash, S., Rezazadeh, S., Shackelford, R. E., Sidransky, D., Tran, P. T., Yang, E. S., & Maxwell, C. A.
- Venue
- Seminars in Cancer Biology
- Publisher
- Elsevier BV
- Published
- 2015-12
- Volume
- 35
- Pages
- S5-S24
- ISSN
- 1044-579X (ISSN-L)
- OpenAlex
- W1981587077
- Cited by
- 336
- References
- 481
- FWCI
- 12.61
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.